Competitive Intelligence: A Substantial Advantage for the Pharmaceutical Sector

“The supreme art of war is to subdue the enemy without fighting” – Sun Zhu, Competitive Intelligence benefits your organization gather and analyzing information related to your competitor’s business models. This deep analysis helps your organization reduce the strategic risks and increase revenue opportunities by attaining deep insights into how the market has changed and…

BySaurabh ChaubeyOctober 11, 2022

THOUGHTSPOT

Role of Wearables in Cardiovascular Domain

The heart is the muscular organ that pumps blood throughout the body. A group of diseases that affect the heart and blood vessels of the body comes under cardiovascular disease (CVD). Heart disease is globally the major cause of death (~17.3M). Irregular heart functions can lead to heart arrhythmia, heart attack, myocardial infarction, and other…

BySaurabh ChaubeyJuly 12, 2022

THOUGHTSPOT

FTC Anti-Trust Policy: Future of Pharmaceutical Industry

Pharmaceutical drugs are the mainstay of the modern medical industry and this necessitates the continuous development of new treatments by brand-name pharmaceutical companies an essential process for saving many lives2. When a generic drug makes its entry into the market, the prices tend to fall drastically, often by as much as 85%. As a result,…

BySaurabh ChaubeyJune 21, 2022

THOUGHTSPOT

Bio-Metaverse: The Inception of New Digital Healthcare

INTRODUCTION The next generation of internet-Metaverse is a combination of Virtual Reality (VR), Augmented Reality (AR), Artificial Intelligence (AI), and ever-increasing connectivity (like 5G networks) to create a more immersive, experimental, and interactive online worlds. The metaverse originated by converging three major technical trends- Telepresence (allowing the virtual presence of people even if they are…

BySaurabh ChaubeyJune 14, 2022

INSIGHTS+

PharmaShots Year in Review: Biosimilars Approvals in 2018

THE US FDA APPROVALS 1. Pfizer's Retacrit (epoetin alfa-epbx, biosimilar) Receives FDA Approval for Anemia Published: 15 May, 2018 | Tags: Pfizer, Retacrit, epoetinalfa-epbx, biosimilar, Receives, FDA, Approval, Anemia 2. Pfizer's Nivestym (filgrastim-aafi, biosmilar) Receives FDA Approval for Neutropenia Published: 20 Jul, 2018 | Tags: (filgrastim-aafi approval biosmilar), Neutropenia, Nivestym, Pfizer, Receives, the US FDA 3. Sandoz's Hymiroz (adalimumab-adaz, biosimilar) Receives the US FDA…

BySaurabh ChaubeyJanuary 8, 2019

Saurabh Chaubey

Competitive Intelligence: A Substantial Advantage for the Pharmaceutical Sector

Role of Wearables in Cardiovascular Domain

FTC Anti-Trust Policy: Future of Pharmaceutical Industry

Bio-Metaverse: The Inception of New Digital Healthcare

PharmaShots Year in Review: Biosimilars Approvals in 2018

Contact US

FOLLOW US